⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of IRCCS Ospedale San Raffaele and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
IRCCS Ospedale San Raffaele
↗Milan, Italy
IRCCS Ospedale San Raffaele is a leading Italian research hospital and scientific institute based in Milan. It integrates basic, translational, and clinical research to bridge the gap between laboratory discovery and patient care, with a strong focus on gene therapy, oncology, and rare diseases.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Academic Medical Center / Translational Research
SIZE & FINANCIALS
Employees:1001-5000
Founded:1972
Ownership:nonprofit
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Commercial (via spin-offs/partnerships)
Modalities:Gene therapy, Cell therapy, Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Genenta Science
Key Partnerships:Cytiva (Genomic medicine), Fondazione Telethon (Gene therapy), Orchard Therapeutics, Intellia Therapeutics, Amgen, AstraZeneca
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Daniela Bellomo - Director of Business Development
LINKS
Website:hsr.it
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with IRCCS Ospedale San Raffaele. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.